pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
NOVO · news · pharmadog
← back to NOVO
News mentioning NOVO
476
stories
Aug 11, 26
Scholar Rock rejigs approval filing after FDA flags violations at Novo plant
biospace
Aug 10, 26
Scholar Rock drops Novo manufacturing site from SMA drug application
endpoints
Aug 10, 26
RevMed, BeOne make clinical trial, Asia deal; MoonLake reports Phase 3 win
endpoints
Aug 10, 26
Scholar Rock ditches Novo’s legacy Catalent plant in FDA refiling of SMA drug
fiercebiotech
Aug 9, 26
Novo Nordisk and Amazon sign AI drug discovery pact, launch London innovation hub
fiercebiotech
Aug 7, 26
STAT+: Pharmalittle: We’re reading about Replimune’s melanoma drug, a Medicare policy change, and more
stat
Aug 7, 26
Is the biotech capital of the world moving?
stat
Aug 7, 26
Novo Nordisk’s CFO on the oral Wegovy rollout and beyond
fiercebiotech
Aug 6, 26
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
globenewswire health
Aug 6, 26
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
globenewswire health
Aug 6, 26
Actimed gets back rights to wasting disease drug, ending $126M deal with Faraday
fiercebiotech
Aug 5, 26
Lilly confident in slow and steady Foundayo launch, as ex-US sales shine
biospace
Aug 5, 26
Lilly, FDA retatrutide biologic dispute comes to a head as submission nears
biospace
Aug 5, 26
Lilly climbs, Novo falls as obesity drug battle intensifies
biopharma dive
Aug 5, 26
Lilly’s $23B Q2 soars over expectations but Foundayo lags Novo’s rival oral GLP-1
biospace
Aug 5, 26
STAT+: Moderna launches early trial of Ebola mRNA vaccine
stat
Aug 5, 26
Novo CEO sees innovation as a matter of survival amid pipeline setbacks
biospace
Aug 5, 26
A COPD drug from China draws $115M in venture funding
biopharma dive
Aug 5, 26
Rumors of biggest pharma merger ever drop amid Q2 earnings, contentious FDA adcomms
biospace
Aug 5, 26
Novo Nordisk eyes bolt-on deals as pipeline disappointments pile up
endpoints
Aug 5, 26
‘It’s been a roller coaster’: Novo Nordisk’s CFO reflects on ‘pressure’ to drive growth
fiercebiotech
Aug 5, 26
Novo CEO accepts ‘couple of setbacks’ in R&D as CagriSema posts more mixed data
fiercebiotech
Aug 4, 26
Novo dips 6% on Wegovy pill stumble despite Q2 earnings beat
biospace
Aug 4, 26
Novo vs. Lilly: Q2's cardiometabolic grudge match
endpoints
Aug 4, 26
Pfizer cuts $2.5B more across R&D, manufacturing in ongoing restructure
biospace
Aug 4, 26
Sanofi-backed Expedition uses $115M series B to advance COPD drug on phase 2 journey
fiercebiotech
Aug 4, 26
Pfizer axes ex-Metsera obesity asset and GIPR prospect in quarterly clearout
fiercebiotech
Aug 4, 26
Pathos AI pads pipeline with $2.2B Alphamab deal, AstraZeneca pact
fiercebiotech
Aug 3, 26
STAT+: Pharmalittle: We’re reading about AstraZeneca-Bristol merger talks, a revised 340B plan, and more
stat
Aug 3, 26
STAT+: Sandoz to pay $478.5 million to settle price-fixing allegations in long-running battle with states
stat
← prev
page 10 of 16
next →
